Neuroprotective effect of Erigeron Breviscapus (vant) Hand-mazz extract on retinal ganglion cells in rabbits with chronic elevated intraocular pressure

1. Anderson DR. Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol. 1989; 108:485-95.10.1016/0002-9394(89)90423-6Open DOISearch in Google Scholar

2. Bathija R, Gupta N, Zangwill L, Weinreb RN. Changing definition of glaucoma. J Glaucoma. 1998; 7:165-9.10.1097/00061198-199806000-00004Open DOISearch in Google Scholar

3. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86:238-42.10.1136/bjo.86.2.238Open DOISearch in Google Scholar

4. Palmberg P. Risk factors for glaucoma progression: Where does intraocular pressure fit in? Arch Ophthalmol. 2001; 119: 897-8.10.1001/archopht.119.6.897Open DOISearch in Google Scholar

5. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trail. Arch Ophthalmol. 2003; 121:48-56.10.1001/archopht.121.1.48Open DOISearch in Google Scholar

6. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998; 126:498-505.10.1016/S0002-9394(98)00272-4Search in Google Scholar

7. The AIGS investigators. Advanced glaucoma intervention study: 7. the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130:429-40.10.1016/S0002-9394(00)00538-9Search in Google Scholar

8. Gao M, Gu M, Liu CZ. Two-step purification of scutellarin from Erigeron breviscapus (vant.) Hand. Mazz. by high-speed counter-current chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2006; n838:139-43.10.1016/j.jchromb.2006.04.03016790369Search in Google Scholar

9. Zhou QS, Zhao YM, Bai X, Li PX, Ruan CG. Effect of new-breviscapine on fibrinolysis and anticoagulation of human vascular endothelial cells (in Chinese). Zhongguo Yao Li Xue Bao. 1992; 13:239-242.Search in Google Scholar

10. Wang ZY, Chen DC, He Y, Ruan CG, Zhang RW. Differential effects of new breviscapine on arachidonic acid metabolisms in blood cells and endothelial cells (in Chinese). Zhongguo Yao Li Xue Bao. 1993; 14: 148-151.Search in Google Scholar

11. Wang NL, Sun XH, Li JZ, Wang JH, Chen XM, Lin D, et al. Neuroprotective effects of erigeron breviscapus (vant) hand-mazz on glaucoma- A multi-center clinical trail. Int J Ophthalmol. 2004;4:587-92.Search in Google Scholar

12. Jiang YQ, Wu ZZ, Mo XJ, Chen XM, Jiang YL. An approach treat the late stage glaucoma with intraocular pressure controlled after trebecuculectomy. Chin Ophthalmic Res. 1991; 9:229-32.Search in Google Scholar

13. Jia L, Liu Z, Luo X, Jiang Y, Wu Z, Liu D. The effect of Qing Guang Kang on the metabolism of retinal ganglion cells of rats after artificial acute high intraocular pressure (in Chinese). Zhonghua Yan Ke Za Zhi. 1995; 31:129-31.Search in Google Scholar

14. Zhu Y, Jiang Y, Liu Z, Luo X, Wu Z. The affect of Erigeron Breviscapus (Vant.) Hand-Mazz on axoplasmic transport of optic nerve in rats with experimentally elevated intraocular pressure (in Chinese). Zhonghua Yan Ke Za Zhi. 2000; 36:289-91.Search in Google Scholar

15. Manni G, Lambiase A, Centofanti M, Mattei E, De Gregorio A, Aloe L, et al. Histopathological evaluation of retinal damage during intraocular hypertension in rabbit: involvement of ganglion cells and nerve fiber layer. Graefes Arch Clin Exp Ophthalmol. 1996; 234 (Suppl 1):S209-13.10.1007/BF023430748871176Search in Google Scholar

16. Zhu MD, Cai FY. Development of experimental chronic intraocular hypertension in the rabbit. Aust N Z Ophthalmol. 1992; 20:225-34.10.1111/j.1442-9071.1992.tb00944.x1449775Search in Google Scholar

17. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002; 120: 1268-79.10.1001/archopht.120.10.1268Open DOISearch in Google Scholar

18. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma: Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126:498-505.10.1016/S0002-9394(98)00272-4Search in Google Scholar

19. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressure: Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126:487-97.10.1016/S0002-9394(98)00223-2Search in Google Scholar

20. Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthamol Vis Sci 2000; 41:3460-3466.Search in Google Scholar

21. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TRKB in experimental glaucoma. Invest Ophthamol Vis Sci. 2000; 41:764-74.Search in Google Scholar

22. Vorwerk CK, Gorla MS, Dreyer EB. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol 1999; 43(Suppl 1) :S142-50.10.1016/S0039-6257(99)00017-XOpen DOISearch in Google Scholar

23. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitrous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996; 114:299-305.10.1001/archopht.1996.01100130295012Open DOISearch in Google Scholar

24. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthamol Vis Sci. 1996; 37: 1618-24.Search in Google Scholar

25. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002; 21:359-93.10.1016/S1350-9462(02)00008-3Open DOISearch in Google Scholar

26. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it-myth and reality. Prog Retin Eye Res. 2001; 20:563-93.10.1016/S1350-9462(01)00004-0Open DOISearch in Google Scholar

27. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary openangle glaucoma: a population-based assessment. Arch Ophthalmol. 1995; 113:216-21.10.1001/archopht.1995.011000201000387864755Open DOISearch in Google Scholar

28. Zhang RW, Yang SY, Lin YY. Studies on chemical constituents of dengzhanhua (Erigeron breviscapus (Vant.) Hand-Mazz). I. The isolation and identification of pyromeconic acid and a new glucoside (in Chinese). Yao Xue Xue Bao. 1981; 16:68-9.Search in Google Scholar

29. Zhang WD, Chen WS, Wang YH, Liu WY, Kong DY, Li HT. Studies on flavone constituents of Erigeron breviscapus (Vant.) Hand.-Mazz (in Chinese). Zhongguo Zhong Yao Za Zhi. 2000; 25:536-8.Search in Google Scholar

30. Zhang WD, Ha TB, Chen WS, Kong DY, Li HT, Wang YH, et al. Study on the structure and activity of new phenolic acid compounds from Erigeron breviscapus (in Chinese). Yao Xue Xue Bao. 2001; 36: 360-3.Search in Google Scholar

31. Zhang WD, Chen WS, Wang YH, Liu WY, Kong DY, Li HT. Two new glycosides from Erigeron breviscapus (Vant.) Hand.-Mazz. Zhongguo (in Chinese). Zhong Yao Za Zhi 2001; 26:689-90.Search in Google Scholar

32. Chu Q, Wu T, Fu L, Ye J. Simultaneous determination of active ingredients in Erigeron breviscapus (Vant.) Hand-Mazz. By capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal. 2005; 37: 535-41.10.1016/j.jpba.2004.11.01815740914Open DOISearch in Google Scholar

33. Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem. 2000; 74:2268-77.10.1046/j.1471-4159.2000.0742268.x10820186Search in Google Scholar